ZENTALIS PHARMACEUTICALS
Zentalis Pharmaceuticals is a clinical-stage biopharmaceutical company focused on developing clinically differentiated, novel small molecule therapeutics that target fundamental biological pathways in cancer. It was founded 2014 and headquartered in New York, United States.
ZENTALIS PHARMACEUTICALS
Social Links:
Industry:
Biopharma Biotechnology Pharmaceutical
Founded:
2014-12-01
Address:
New York, New York, United States
Country:
United States
Website Url:
http://www.zentalis.com
Total Employee:
101+
Status:
Active
Contact:
212-433-3791
Email Addresses:
[email protected]
Total Funding:
517.1 M USD
Technology used in webpage:
Viewport Meta IPhone / Mobile Compatible SPF SSL By Default Google Analytics Apple Mobile Web Clips Icon WordPress Google Universal Analytics Wordpress Plugins Nginx
Similar Organizations
Arcellx
Arcellx is a clinical-stage biotechnology company that provides patients with superior immune cell therapies.
Day One Biopharmaceuticals
Day One Biopharmaceuticals is a biotechnology company that focuses on developing new cancer therapies for patients of all ages.
Edgewise Therapeutics
Edgewise Therapeutics is a clinical-stage biopharmaceutical company focused on the discovery, development and commercialization.
Reata Pharmaceuticals
Reata Pharmaceuticals is a biopharmaceutical company that develops drugs for cancer, inflammation, and neurodegenerative diseases.
Palisade Bio
Palisade Bio is a clinical-stage biopharmaceutical company developing novel therapies for acute and chronic gastrointestinal complications.
Sirnaomics
Sirnaomics is a biopharmaceutical company developing therapeutics for critical human diseases by using RNA interference technology.
Current Advisors List
Current Employees Featured
Founder
Stock Details
Investors List
Pfizer
Pfizer investment in Post-IPO Equity - Zentalis Pharmaceuticals
Redmile Group
Redmile Group investment in Series C - Zentalis Pharmaceuticals
Viking Global Investors
Viking Global Investors investment in Series C - Zentalis Pharmaceuticals
Eventide
Eventide investment in Series C - Zentalis Pharmaceuticals
Matrix Capital
Matrix Capital investment in Series C - Zentalis Pharmaceuticals
Perceptive Advisors
Perceptive Advisors investment in Series C - Zentalis Pharmaceuticals
Surveyor Capital
Surveyor Capital investment in Series C - Zentalis Pharmaceuticals
Matrix Capital
Matrix Capital investment in Series B - Zentalis Pharmaceuticals
Viking Global Investors
Viking Global Investors investment in Series B - Zentalis Pharmaceuticals
Key Employee Changes
Date | New article |
---|---|
2022-05-16 | Zentalis Pharmaceuticals Appoints Oncology Clinical Development Veteran Dr. Kimberly Blackwell as Chief Executive Officer |
Official Site Inspections
http://www.zentalis.com Semrush global rank: 2.64 M Semrush visits lastest month: 6.45 K
- Host name: aacb0a264e514dd48.awsglobalaccelerator.com
- IP address: 75.2.70.75
- Location: Seattle United States
- Latitude: 47.54
- Longitude: -122.3032
- Metro Code: 819
- Timezone: America/Los_Angeles
- Postal: 98108